Engineers Gate Manager LP Celldex Therapeutics, Inc. Transaction History
Engineers Gate Manager LP
- $4.27 Billion
- Q2 2024
A detailed history of Engineers Gate Manager LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 7,754 shares of CLDX stock, worth $263,403. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,754
Previous 26,606
70.86%
Holding current value
$263,403
Previous $1.12 Million
74.37%
% of portfolio
0.01%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.4MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$274 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$159 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$127 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$115 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$113 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.59B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...